Skip to search formSkip to main contentSkip to account menu

Extended Release Dosage Form

Known as: Extended Release Dose Form, ER, Extended Release 
A solid, semi-solid, solution or suspension designed to release active and/or inert ingredient(s) at a controlled, prolonged rate so as to reduce… 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Dosage Forms

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Response to Comment on Cefalu et al. Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes…
We thank Dr. Garvey for his letter (1) in response to our 2015 Diabetes Care Editors’ Expert Forum on the prevention of type 2… 
2014
2014
Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach.
Highly Cited
2009
Highly Cited
2009
Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
2007
2007
Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study.
2007
2007
New release cell for NMR microimaging of tablets. Swelling and erosion of poly(ethylene oxide).
Highly Cited
2006
Highly Cited
2006
Symptom‐specific efficacy of tolterodine extended release in patients with overactive bladder: the IMPACT trial
We evaluated the efficacy of tolterodine extended release (ER) for patients’ most bothersome overactive bladder (OAB) symptom in… 
Highly Cited
2005
Highly Cited
2005
In vitro versus canine data for predicting input profiles of isosorbide-5-mononitrate from oral extended release products on a confidence interval basis.
Highly Cited
2004
Highly Cited
2004
Efficacy of antimuscarinic therapy for overactive bladder with varying degrees of incontinence severity.
PURPOSE We analyze the efficacy of tolterodine extended release (ER) for overactive bladder in patients with severe incontinence… 
Highly Cited
2004
Highly Cited
2004
Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial
Overactive bladder (OAB) has a significant impact on a patient’s health-related quality of life (HRQoL). This study assessed the… 
Highly Cited
1999
Highly Cited
1999
Poly-L-lysine improves gene transfer with adenovirus formulated in PLGA microspheres
In vivo gene transfer with recombinant adenovirus vectors can be hindered by the immunogenicity of the adenovirus capsid proteins… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)